Runhe Biology Medicine Technology

Zhejiang Runhe Biology Medicine Technology is a biopharmaceutical company headquartered in Huzhou, China, specializing in the research, development, and large-scale manufacturing of peptide-based therapeutics and high-end generic drugs. The company utilizes a sophisticated technology platform for peptide synthesis, purification, and chemical modification to produce high-purity active pharmaceutical ingredients (APIs) and finished dosage forms. Their product portfolio primarily targets metabolic diseases, endocrinology, and oncology, with a strong focus on GLP-1 analogues and somatostatin derivatives. In addition to its internal drug pipeline, Runhe operates as a CDMO, providing specialized peptide manufacturing services to global pharmaceutical partners under international GMP standards.